These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Immunization against varicella and zoster]. Floret D. Bull Acad Natl Med; 2007 Jun; 191(6):1051-64; discussion 1064-7. PubMed ID: 18402164 [Abstract] [Full Text] [Related]
3. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT, Loparev VN, Schmid DS, Jumaan AO, Snow SL. Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809 [Abstract] [Full Text] [Related]
4. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations. Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369 [Abstract] [Full Text] [Related]
5. Successes and remaining challenges after 10 years of varicella vaccination in the USA. Davis MM. Expert Rev Vaccines; 2006 Apr; 5(2):295-302. PubMed ID: 16608428 [Abstract] [Full Text] [Related]
6. Varicella prevention in the United States: a review of successes and challenges. Marin M, Meissner HC, Seward JF. Pediatrics; 2008 Sep; 122(3):e744-51. PubMed ID: 18762511 [Abstract] [Full Text] [Related]
7. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus]. Bonmarin I, Santa-Olalla P, Lévy-Bruhl D. Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741 [Abstract] [Full Text] [Related]
9. Cost-effectiveness of varicella vaccination programs: an update of the literature. Rozenbaum MH, van Hoek AJ, Vegter S, Postma MJ. Expert Rev Vaccines; 2008 Aug; 7(6):753-82. PubMed ID: 18665775 [Abstract] [Full Text] [Related]
10. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N. Vaccine; 2011 Mar 16; 29(13):2411-20. PubMed ID: 21277405 [Abstract] [Full Text] [Related]
11. Is it time to introduce varicella vaccination? Murphy JF. Ir Med J; 2005 Mar 16; 98(3):68. PubMed ID: 15869059 [No Abstract] [Full Text] [Related]
12. Universal varicella vaccination: efficacy trends and effect on herpes zoster. Goldman GS. Int J Toxicol; 2005 Mar 16; 24(4):205-13. PubMed ID: 16126614 [Abstract] [Full Text] [Related]
13. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. de Melker H, Berbers G, Hahné S, Rümke H, van den Hof S, de Wit A, Boot H. Vaccine; 2006 May 01; 24(18):3946-52. PubMed ID: 16564115 [Abstract] [Full Text] [Related]
14. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF. J Infect Dis; 2008 Mar 01; 197 Suppl 2():S224-7. PubMed ID: 18419401 [Abstract] [Full Text] [Related]
15. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study. Horn J, Damm O, Greiner W, Hengel H, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Karch A, Mikolajczyk RT. BMC Med; 2018 Jan 09; 16(1):3. PubMed ID: 29316913 [Abstract] [Full Text] [Related]
16. Different vaccination strategies in Spain and its impact on severe varicella and zoster. Gil-Prieto R, Walter S, Gonzalez-Escalada A, Garcia-Garcia L, Marín-García P, Gil-de-Miguel A. Vaccine; 2014 Jan 03; 32(2):277-83. PubMed ID: 24275483 [Abstract] [Full Text] [Related]
17. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany. Wutzler P, Neiss A, Banz K, Goertz A, Bisanz H. Med Microbiol Immunol; 2002 Oct 03; 191(2):89-96. PubMed ID: 12410347 [Abstract] [Full Text] [Related]
18. Varicella vaccination in children with atopic eczema. Kienast AK, Kreth HW, Höger PH. J Dtsch Dermatol Ges; 2007 Oct 03; 5(10):875-80. PubMed ID: 17910669 [Abstract] [Full Text] [Related]
19. Is Europe ready to embrace a policy of universal varicella vaccination? Ramet J, Weil-Olivier C, Sedlak W, Confederation of the European Specialists of Paediatrics (CESP)/European Academy of Paediatrics (EAP) CESP/EAP. Int J Clin Pract; 2005 Nov 03; 59(11):1326-33. PubMed ID: 16236088 [Abstract] [Full Text] [Related]
20. [Chickenpox: sufficient reasons for the introduction of vaccination]. Rümke H, de Groot R. Ned Tijdschr Geneeskd; 2006 Dec 02; 150(48):2630-2. PubMed ID: 17205937 [Abstract] [Full Text] [Related] Page: [Next] [New Search]